Last reviewed · How we verify

NCT03206528

Clinical Evaluation of the Vital Signs Monitoring System (VSMS)

Status unknown Last updated 2 July 2017
What this trial tests

trial testing Vital Signs Monitoring System in Body Temperature in 100 participants. Status unknown.

Timeline
25 April 2017
Primary endpoint
31 July 2017
31 July 2017

Quick facts

Lead sponsorG Medical Innovations Ltd.
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date25 April 2017
Primary completion31 July 2017
Estimated completion31 July 2017
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

G Medical Innovations Ltd.

Who can join

18 and older, any sex, with Body Temperature or Oxygen Saturation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational, cohort-based, single-site, prospective study conducted in accordance with ISO 14155-1:2003 and ISO 14155-1:2011. The primary objectives are to evaluate the accuracy of the device's measurements/readings in comparison to a gold standard or standard of care patient monitor.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Body Temperature

Currently open trials in the same condition.

Other G Medical Innovations Ltd. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03206528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing